04:59 PM EDT, 06/18/2025 (MT Newswires) -- Douglas F Kling, Chief Operating Officer, on June 16, 2025, sold 100,000 shares in Newamsterdam Pharma ( NAMS ) for $1,929,141. Following the Form 4 filing with the SEC, Kling has control over a total of 44,000 common shares of the company, with 44,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1936258/000095017025087937/xslF345X05/ownership.xml